D-Wave finalizes Commerce agreement for up to $100 million in CHIPS funding

D-Wave Quantum (NASDAQ: QBTS) announced September 8 that it had executed a definitive agreement with the U.S. Department of Commerce, based on a previously announced letter of intent, giving it access to up to $100 million in U.S. CHIPS and Science Act funding. The announcement accompanies its Form 8-K, accession number 0001907982-26-000141.

From intent to a definitive agreement

The September 8 announcement, issued from Palo Alto, moves the previously disclosed letter of intent to an executed agreement. The Form 8-K identifies September 4, 2026, as the Award Date and earliest reported event; September 8 is the public announcement date. Access to funding of up to $100 million does not establish that the full amount has been disbursed.

Public funding with an equity condition

Commerce will receive a minority, non-controlling equity stake in D-Wave as a condition for receiving the funds. That makes the equity condition part of the funding story alongside the research ambitions. The announcement does not support treating the agreement as a government takeover.

D-Wave says the funding is expected to accelerate research, development and scaling of its superconducting annealing and gate-model quantum systems. It frames the award as a way to expand domestic quantum capabilities, strengthen the underlying supply chain and bring increasingly powerful systems to market.

For U.S. quantum industrial policy, the significance is the connection between public support for research and the capacity to scale technology domestically. The agreement commits a funding framework to that effort; whether it produces the capabilities described by D-Wave remains a question of execution.

The roadmap remains a set of targets

The company's roadmap includes a hundred-thousand-qubit annealing system and further development of a ten-thousand-qubit gate-model system designed to enable a hundred logical qubits capable of successfully performing more than a million operations. D-Wave names quantum chemistry and quantum AI among potential applications. These are forward-looking company targets, not demonstrated specifications or completed systems.

The next useful distinction is between access to capital and evidence of technical delivery. Subsequent disclosures would need to establish funds received, the equity issued under the agreement and progress toward the stated systems before readers could judge how much of the funding promise has translated into operating capability.